Hims & Hers Health is trading 4.2% lower at €22.80, with no clear company-specific catalyst identified. - The move occurred November 3; the next scheduled earnings report is November 9. - Recent coverage concerns a securities class action and its lead-plaintiff deadline, but available information does not establish that it caused the decline. - Supplied market indices were flat, so broad-market direction does not clearly explain the move.